F. Leitner
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 20
- Antibiotics Pharmacokinetics and Efficacy 17
- Microbial Natural Products and Biosynthesis 3
-
- Antibiotic Resistance in Bacteria 16
- Co-authors
- M Misiek (15 shared papers)K. E. Price (17 shared papers)T. A. Pursiano (10 shared papers)R. E. Buck (9 shared papers)R E Kessler (3 shared papers)Sidney Cohen (4 shared papers)Helen M. Sweeney (3 shared papers)J V Desiderio (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (11 papers)The Journal of Antibiotics (4 papers)Journal of Bacteriology (3 papers)Chemotherapy (1 paper)Infection (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
F. Leitner
29 papers receiving 447 citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 250
- Pharmacology 386
- Applied Microbiology and Biotechnology 30
- Clinical Biochemistry 47
- Microbiology 36
Countries citing papers authored by F. Leitner
This map shows the geographic impact of F. Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Leitner more than expected).
Fields of papers citing papers by F. Leitner
This network shows the impact of papers produced by F. Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Leitner. The network helps show where F. Leitner may publish in the future.
Co-authors
The 13 scholars most cited alongside F. Leitner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 141 | |
| 2 | 1972 | 66 | |
| 3 | 1987 | 55 | |
| 4 | 1976 | 43 | |
| 5 | 1975 | 26 | |
| 6 | 1973 | 24 | |
| 7 | 1990 | 23 | |
| 8 | 1975 | 19 | |
| 9 | BL-P 1654, a new broad-spectrum penicillin with marked antipseudomonal activity. | 1970 | 15 |
| 10 | 1979 | 14 | |
| 11 | Laboratory studies with a new cephalosporanic acid derivative. | 1969 | 14 |
| 12 | 1982 | 13 | |
| 13 | 1969 | 11 | |
| 14 | 1965 | 10 | |
| 15 | 1967 | 10 | |
| 16 | 1962 | 9 | |
| 17 | 1963 | 9 | |
| 18 | 1973 | 9 | |
| 19 | 1979 | 8 | |
| 20 | 1980 | 7 |
About F. Leitner
F. Leitner is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Molecular Biology and Epidemiology, having authored 29 papers that have together received 555 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (16 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Cancer therapeutics and mechanisms (3 papers), Microbial Natural Products and Biosynthesis (3 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Molecular Medicine (250 citations), Pharmacology (386 citations), Applied Microbiology and Biotechnology (30 citations), Clinical Biochemistry (47 citations) and Microbiology (36 citations). F. Leitner has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include M Misiek, K. E. Price, T. A. Pursiano, R. E. Buck, R E Kessler, Sidney Cohen, Helen M. Sweeney, J V Desiderio, Matthew McGregor and George E. Wright. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Journal of Bacteriology, Chemotherapy and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.